Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 3,148 | 1,287 | 1,219 | 469 | 690 |
| Operating Income | -3,148 | -1,287 | -1,219 | -469 | -690 |
| Other Income | -562 | 2,181 | 0 | 0 | 0 |
| Pre-tax Income | -3,710 | 894 | -1,219 | -469 | -690 |
| Net Income Continuous | -3,710 | 894 | -1,219 | -469 | -690 |
| Net Income | $-3,710 | $894 | $-1,219 | $-469 | $-690 |
| EPS Basic Total Ops | -55.20 | 24.79 | -28.24 | -10.88 | -16.82 |
| EPS Basic Continuous Ops | -55.20 | 24.01 | -28.27 | -10.88 | -16.00 |
| EPS Diluted Total Ops | -55.20 | 24.79 | -28.24 | -10.88 | -16.82 |
| EPS Diluted Continuous Ops | -55.20 | 24.01 | -28.27 | -10.88 | -16.00 |
| EPS Diluted Before Non-Recurring Items | -55.28 | 24.00 | -28.83 | N/A | N/A |
| EBITDA(a) | $-3,148 | $-1,287 | $-1,219 | $-469 | $-690 |